Vivo M - Search Results

1

p14ARF interacts with the focal adhesion kinase and protects cells from anoikis.

Vivo M, Fontana R, Ranieri M, Capasso G, Angrisano T, Pollice A, Calabrò V, La Mantia G. Vivo M, et al. Oncogene. 2017 Aug 24;36(34):4913-4928. doi: 10.1038/onc.2017.104. Epub 2017 Apr 24. Oncogene. 2017. PMID: 28436949 Free PMC article.

2

The human tumor suppressor arf interacts with spinophilin/neurabin II, a type 1 protein-phosphatase-binding protein.

Vivo M, Calogero RA, Sansone F, Calabrò V, Parisi T, Borrelli L, Saviozzi S, La Mantia G. Vivo M, et al. J Biol Chem. 2001 Apr 27;276(17):14161-9. doi: 10.1074/jbc.M006845200. Epub 2001 Jan 30. J Biol Chem. 2001. PMID: 11278317 Free article.

3

The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63.

Calabrò V, Mansueto G, Parisi T, Vivo M, Calogero RA, La Mantia G. Calabrò V, et al. Among authors: vivo m. J Biol Chem. 2002 Jan 25;277(4):2674-81. doi: 10.1074/jbc.M107173200. Epub 2001 Nov 19. J Biol Chem. 2002. PMID: 11714701 Free article.

4

Functional and physical interaction of the human ARF tumor suppressor with Tat-binding protein-1.

Pollice A, Nasti V, Ronca R, Vivo M, Lo Iacono M, Calogero R, Calabrò V, La Mantia G. Pollice A, et al. Among authors: vivo m. J Biol Chem. 2004 Feb 20;279(8):6345-53. doi: 10.1074/jbc.M310957200. Epub 2003 Dec 9. J Biol Chem. 2004. PMID: 14665636 Free article.

5

TBP-1 protects the human oncosuppressor p14ARF from proteasomal degradation.

Pollice A, Sepe M, Villella VR, Tolino F, Vivo M, Calabrò V, La Mantia G. Pollice A, et al. Among authors: vivo m. Oncogene. 2007 Aug 2;26(35):5154-62. doi: 10.1038/sj.onc.1210313. Epub 2007 Mar 5. Oncogene. 2007. PMID: 17334400

6

The promiscuity of ARF interactions with the proteasome.

Pollice A, Vivo M, La Mantia G. Pollice A, et al. Among authors: vivo m. FEBS Lett. 2008 Oct 15;582(23-24):3257-62. doi: 10.1016/j.febslet.2008.09.026. Epub 2008 Sep 19. FEBS Lett. 2008. PMID: 18805416 Free article. Review.

7

Homeodomain protein Dlx3 induces phosphorylation-dependent p63 degradation.

Di Costanzo A, Festa L, Duverger O, Vivo M, Guerrini L, La Mantia G, Morasso MI, Calabrò V. Di Costanzo A, et al. Among authors: vivo m. Cell Cycle. 2009 Apr 15;8(8):1185-95. doi: 10.4161/cc.8.8.8202. Epub 2009 Apr 16. Cell Cycle. 2009. PMID: 19282665 Free PMC article.

8

Downregulation of DeltaNp63alpha in keratinocytes by p14ARF-mediated SUMO-conjugation and degradation.

Vivo M, Di Costanzo A, Fortugno P, Pollice A, Calabrò V, La Mantia G. Vivo M, et al. Cell Cycle. 2009 Nov 1;8(21):3545-51. doi: 10.4161/cc.8.21.9954. Epub 2009 Dec 1. Cell Cycle. 2009. PMID: 19829080

9

A dominant mutation etiologic for human tricho-dento-osseous syndrome impairs the ability of DLX3 to downregulate ΔNp63α.

Di Costanzo A, Festa L, Roscigno G, Vivo M, Pollice A, Morasso M, La Mantia G, Calabrò V. Di Costanzo A, et al. Among authors: vivo m. J Cell Physiol. 2011 Aug;226(8):2189-97. doi: 10.1002/jcp.22553. J Cell Physiol. 2011. PMID: 21520071 Free article.

10

Mimicking p14ARF phosphorylation influences its ability to restrain cell proliferation.

Vivo M, Ranieri M, Sansone F, Santoriello C, Calogero RA, Calabrò V, Pollice A, La Mantia G. Vivo M, et al. PLoS One. 2013;8(1):e53631. doi: 10.1371/journal.pone.0053631. Epub 2013 Jan 7. PLoS One. 2013. PMID: 23308265 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters